Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 870 of 5804
-
Could an arthritis drug shield heart and kidneys in metabolic syndrome?
Disease control Not yet recruitingThis is a prospective, randomized, open-label, parallel-controlled clinical trial to evaluate the efficacy and safety of targeted IL-17A inhibition with secukinumab on cardiovascular and renal endpoints in 100 patients with cardiorenal metabolic syndrome and atherosclerotic cardi…
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
CT scans could make heart artery procedures faster and safer
Disease control Not yet recruitingThe CT-PLAN PCI trial will evaluate whether CCTA-guided PCI improves procedural efficiency compared with routine PCI (without pre-procedural CCTA-guidance for PCI planning) using procedural time as the primary endpoint. Key secondary outcomes will include contrast volume, radiati…
Phase: NA • Sponsor: Minneapolis Heart Institute Foundation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a new drug heal bleeding ulcers faster? trial pits tegoprazan against lansoprazole
Disease control Not yet recruitingThis clinical trial compares two medicines used to treat bleeding stomach ulcers in people in Indonesia. The researchers want to find out whether tegoprazan or lansoprazole is better at healing these ulcers after 2 weeks of treatment. The main question this trial aims to answer …
Phase: PHASE2 • Sponsor: Indonesia University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Smart blood culture bottle aims to identify sepsis-causing bacteria in hours, not days
Knowledge-focused Recruiting nowIn the context of a bacteremia, although significant progress has been made in speeding up pathogen identification once a blood culture bottle turns positive, few cost-effective solutions have been proposed to improve the earlier stages of the process-specifically, from blood col…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New HIV combo pill tested for rapid start in 100 patients
Disease control Not yet recruitingProtocol title: "Efficacy and safety of doravirine in the rapid initiation of highly active antiretroviral therapy (HAART) in HIV-1positive patients without prior treatment."
Phase: PHASE4 • Sponsor: Fundación Huésped • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Fatty liver may be a hidden driver of heart attacks in diabetes
Knowledge-focused Not yet recruitingThis study aims to address the following key scientific question by establishing a large-scale, high-standard clinical cohort: the independent contribution of MASLD and its progression to liver fibrosis on cardiovascular outcomes in patients with T2DM, after excluding the confoun…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Can a Cholesterol-Lowering injection help lung cancer patients stay on a key treatment?
Disease control Not yet recruitingThis prospective single-arm clinical study plans to enroll 29 participants with unresectable stage IIIB-IV ALK fusion-positive non-small cell lung cancer (NSCLC). Eligible patients must be aged ≥18 years with an ECOG performance status of 0-2 and have developed grade 1-3 hypercho…
Phase: PHASE4 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Stem cell donation: one shot or two? trial seeks best way to mobilize cells
Disease control Recruiting nowNational and international guidelines/consensus recommend G-CSF (granulocyte colony-stimulating factor) at 10 μg/kg/day as a single daily dose or divided into two daily doses for mobilization in healthy donors for allogeneic hematopoietic stem cell transplantation. However, there…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a daily electric zap to the eye preserve sight in dry AMD?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of an electric stimulator for medical use by personal (LRTPM1) in patients with early to intermediate dry age-related macular degeneration. The main questions this study aims to answer are: * Does the invest…
Phase: NA • Sponsor: Nu Eyne Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Smart oxygen device aims to free lung patients from constant monitoring
Symptom relief Recruiting nowMany patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course. Practitioners prescribe O2 to patients with chronic lung disease in hopes of…
Phase: NA • Sponsor: Minnesota HealthSolutions • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could a simple nutrient boost baby brain development in all pregnancies?
Disease control Recruiting nowA double-blind, randomized, placebo-controlled trial (RCT; NCT04395196) of prenatal choline supplementation is ongoing (1) to assess the effectiveness of maternal choline supplementation during pregnancy to mitigate effects of PAE on three primary outcomes: infant recognition mem…
Phase: PHASE2 • Sponsor: Wayne State University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Blood test timing could unlock secrets of advanced breast cancer
Knowledge-focused Recruiting nowThis multicenter, prospective observational cohort study aims to investigate the impact of circulating tumor DNA (ctDNA) level and key actionable gene mutation status on prognosis and treatment response in patients with advanced breast cancer.
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Could an Anti-Inflammatory diet designed for Crohn's disease also tame IBS?
Disease control Not yet recruitingBackground: Irritable Bowel Syndrome (IBS) affects approximately 4.1% of the global population and imposes a significant personal and healthcare burden. Recent evidence highlights the role of low-grade inflammation, impaired intestinal permeability and gut microbiota dysbiosis in…
Phase: NA • Sponsor: Ariel University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Brain wave sync: a new approach to boost memory in dementia
Symptom relief Recruiting nowWorking memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remem…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Food aid may boost cancer treatment completion in food-insecure patients
Disease control Recruiting nowProspective cohort and descriptive study aimed at identifying cancer patients experiencing food insecurity at Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center. The study will involve evaluating the impact of a food assistance intervention on treatment adh…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can culturally tailored programs help black smokers quit for good?
Disease control Recruiting nowThe overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are mo…
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New blood pressure drug HCP1803-4 faces final test
Disease control Not yet recruitingA Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
Phase: PHASE3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Radiation and drug combo shows promise for tough liver cancers
Disease control Not yet recruitingThis is a prospective, single-arm, single-center exploratory clinical study designed to evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) combined with QL1706 in patients with hepatocellular carcinoma who have received one prior line of systemic thera…
Phase: PHASE4 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Wearable gadget could protect dialysis Patients' hearts and brains
Disease control Not yet recruitingKidney failure is common. In some people the ability of the kidneys to clean poisons out of the blood gets so low they need to be hooked up to a machine three times a week to do it for them. This is called dialysis. Unfortunately, although this treatment removes those waste produ…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
App sends mindfulness exercises right after weight regain to keep dieters on track
Disease control Recruiting nowThis trial will test the effectiveness of a weight loss maintenance intervention designed to help participants respond more adaptively to weight regain. Participants will be randomly assigned to one of two conditions. In one condition, participants will receive brief exercises (e…
Phase: NA • Sponsor: ORI Community and Evaluation Services • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC